Saakshi Medtech & Panels Q2 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹708 Cr
- P/E
- 57.62
- ROE
- 11.80%
- PEG
- -240.08
- Price to sales
- 6.12
- Debt to equity
- 0.23
- 52W high / low
- ₹381 / ₹161
- Sales growth (5Y)
- 14.08%
- EBITDA margin
- 19.24%
- Net profit margin
- 10.64%
- Promoter holding
- 74.82%
- Sales (last year)
- ₹116 Cr
Incorporated in 2009, Saakshi Medtech & Panels Ltd deals in Electrical Control Panels, Medical X-Ray Systems, Fabrication & Wire Harness[1]
Guidance scorecard · Q2 FY26 call
What Saakshi Medtech & Panels Ltd's management guided
and where it ranks in Electrical Equipment
Electrical Equipment
RevenueQ2 FY26 call
10–20%- The company targets revenue of around Rs. 140 crores for the current financial year FY'26, with H2 expected to outperform H1 by roughly 15%.
- Significant growth drivers include aerospace and EV business segments, showing strong momentum and new opportunities.
- The aerospace segment has seen nearly a 7-fold growth in H1 FY'26 compared to H1 FY'25 and is expected to contribute up to 20% of revenue within a couple of years.
- Radiator business is set to contribute significantly starting FY'27, supported by a new facility and early customer interest.
- Order book visibility is typically quarterly; currently, about Rs. 50 crores of orders for the ongoing quarter, with defense orders being a small portion (~5%).
2 more points from Saakshi Medtech & Panels Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ2 FY26 call
FlatSee what Saakshi Medtech & Panels Ltd said on margins — free account, 30 seconds.
CapexQ2 FY26 call
Planned- Current CAPEX includes ongoing infrastructure build-out with Rs. 15 crores invested and Rs. 9.4 crores in CWIP.
- New term loans have been taken for constructing the first floor of the newly acquired facility.
- Final CAPEX of around Rs. 5 crores is expected for completing the new facility, which consolidates three previous locations.
- No significant new CAPEX is planned beyond this as future expansion and growth will be funded mainly through cash flows generated by the business, without additional debt.
- Investments include certifications and qualifications for aerospace business, e.g., AS9100 and ongoing NADCAP certification, enabling future exponential growth in aerospace vertical.
2 more points from Saakshi Medtech & Panels Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ2 FY26 call
None plannedSee what Saakshi Medtech & Panels Ltd said on fundraising — free account, 30 seconds.
Order bookQ2 FY26 call
Rising- Current quarter order book stands at approximately Rs. 50 crores.
- Defense portion forms about 5% of the current order book.
- The Mahindra EV Panel's 5-year order remains intact with ongoing execution; Rs. 10 crores executed from Feb '24 to Sept '25, with around Rs. 230 crores pending over the next 4 years.
- The company typically has rolling quarterly visibility on orders rather than a long-term order book.
2 more points from Saakshi Medtech & Panels Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Electrical Equipment
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Electrical Equipment companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹72,673 Cr | 18.1 | |
| 2 | 40%+ | Up 2%+ | ₹21,700 Cr | 158.1 | |
| 3 | 40%+ | Up 2%+ | ₹491 Cr | 12.2 | |
| 4 | 40%+ | Up 0–2% | ₹12,434 Cr | 48.4 | |
| 5 | 40%+ | Up 0–2% | ₹2,042 Cr | 35.4 | |
| 6 | 40%+ | Up 0–2% | ₹529 Cr | 7.0 |
Sign up free to see every company in the sector ranking and track Saakshi Medtech & Panels Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Electrical Equipment rankingFinancials of Saakshi Medtech & Panels Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Saakshi Medtech & Panels Ltd
Quarterly Results
Quarter-by-quarter operating performance
Financials of Saakshi Medtech & Panels Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 61 | 60 | 92 | 122 | 122 | 92 | 116 |
| Expenses + | 50 | 54 | 76 | 101 | 102 | 82 | 93 |
| Operating Profit | 11 | 6 | 16 | 21 | 20 | 10 | 22 |
| OPM % | 18% | 10% | 17% | 17% | 16% | 11% | 19% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 2 | 1 | 1 | 1 | 2 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 3 | 4 | 4 | 5 |
| Profit before tax | 8 | 3 | 13 | 17 | 15 | 7 | 17 |
| Tax % | 24% | 33% | 26% | 25% | 24% | 28% | 26% |
| Net Profit + | 6 | 2 | 9 | 12 | 11 | 5 | 12 |
| EPS in Rs | 6.41 | 2.67 | 6.96 | ||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Saakshi Medtech & Panels Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 |
| Reserves | 15 | 18 | 27 | 40 | 76 | 80 | 93 |
| Borrowings + | 19 | 22 | 16 | 20 | 18 | 18 | 25 |
| Other Liabilities + | 11 | 14 | 19 | 31 | 19 | 15 | 21 |
| Total Liabilities | 48 | 56 | 65 | 93 | 131 | 131 | 157 |
| Fixed Assets + | 22 | 22 | 26 | 34 | 62 | 60 | 83 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 13 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 26 | 34 | 39 | 59 | 68 | 58 | 64 |
| Total Assets | 48 | 56 | 65 | 93 | 131 | 131 | 157 |
Financials of Saakshi Medtech & Panels Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 11 | 0 | 11 | 11 | 8 | 3 | |
| Cash from Investing Activity + | -6 | -1 | -5 | -11 | -31 | -15 | |
| Cash from Financing Activity + | -3 | 2 | -7 | 2 | 36 | -1 | |
| Net Cash Flow | 2 | 1 | -1 | 2 | 12 | -12 | |
| Free Cash Flow | 4 | -1 | 5 | -0 | -24 | -12 | |
| CFO/OP | 115% | 28% | 87% | 73% | 64% | 50% |
Financials of Saakshi Medtech & Panels Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 90 | 70 | 69 | 52 | 86 | 83 |
| Inventory Days | 74 | 95 | 81 | 109 | 102 | 129 | 122 |
| Days Payable | 73 | 97 | 83 | 93 | 43 | 50 | 60 |
| Cash Conversion Cycle | 63 | 88 | 67 | 84 | 110 | 165 | 144 |
| Working Capital Days | -5 | 7 | 30 | 36 | 88 | 129 | 94 |
| ROCE % | 12% | 32% | 33% | 19% | 6% | 14% |
Guidance history
How Saakshi Medtech & Panels Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q2 FY26 call → | 10–20% | Flat | Planned | None planned | Rising |
| Q2 FY25 call → | 20–40% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
91 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +115.3% | 94% |
| Last 6 months | +55.7% | 90% |
| Last 3 months | +22.3% | 88% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Saakshi Medtech & Panels Ltd: 0.4 × 94 + 0.4 × 90 + 0.2 × 88 = 91.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Saakshi Medtech & Panels Ltd's management said in earlier quarters
Others in Electrical Equipment this season
- Ram Ratna Wires (Q2 FY27)
Quarter Revenue (Consolidated):** ₹1,96,195.19 lakhs for Q2 FY2027 (30-09-2026) . Key results statement takeaways from Ram Ratna Wires Ltd's Q2 FY27 results sta
- Suzlon Energy Ltd (Q2 FY27)
Q2 FY27 consolidated net deliveries: 710 MW, up from 565 MW in Q2 FY26 (25.7% YoY increase). Key results statement takeaways from Suzlon Energy Ltd's Q2 FY27 ea
- Yash Highvoltage Ltd (Q2 FY27)
Bushings volume saw a 40% growth in H1 FY27 compared to H1 FY26, indicating strong volume momentum. Key concall takeaways from Yash Highvoltage Ltd's Q2 FY27…
- Volt.Transform. (Q2 FY27)
Revenue from operations for the quarter ended 30th September 2026: ₹68,419.19 lakh . Key results statement takeaways from Voltamp Transformers Ltd's Q2 FY27 ear